Oberhausen, Germany

Lars Bärfacker

This inventor holds 37 USPTO granted patents and 12 published patent applications and 17 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Boehringer Ingelheim International Gmbh. Active years: 2007-2024.

USPTO Granted Patents = 37 

% Patents Active = 37.8

 

Average Co-Inventor Count = 9.6

ph-index = 9

Forward Citations = 205(Granted Patents)


Location History:

  • Oberhausen, DE (2007 - 2017)
  • Düsseldorf, DE (2017 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Akt Kinase Inhibitors
Heterocyclic Compounds
Cardiovascular Treatments
Dihydropyridine Derivatives
Pyrazolepyrimidines
Substituted Pyrimidines
Isothiazoles
Amines
N-Methylbenzimidazoles
Indazoles
Pyridines
Cyanopyrimidinones
37 patents (USPTO):Explore Patents

As a specialist in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can write about inventor Lars Bärfacker based on the details you provided.

Title: Unveiling the Innovation Journey of Lars Bärfacker

Introduction: Lars Bärfacker, a prolific inventor based in Oberhausen, Germany, has left a significant mark in the field of pharmaceuticals with his remarkable contributions. With an impressive portfolio of 34 patents, Lars Bärfacker continues to drive innovation in the industry with his groundbreaking discoveries.

Latest Patents: Among his recent patents, Lars Bärfacker has introduced two groundbreaking inventions. The first patent is related to 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones - compounds that act as inhibitors of Bub1 kinase, showcasing his expertise in developing pharmaceutical solutions. The second patent focuses on N-Methylbenzimidazoles as mIDH1 inhibitors, designed for the treatment of diseases like neoplasms.

Career Highlights: Lars Bärfacker has honed his skills and expertise while working at renowned companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His innovative mindset and dedication to advancing pharmaceutical technology have led to groundbreaking discoveries that have the potential to revolutionize the healthcare industry.

Collaborations: Throughout his illustrious career, Lars Bärfacker has collaborated with esteemed professionals in the field, including Karl-Heinz Schlemmer and Peter Kolkhof. These collaborations have not only enriched his projects but have also fostered a culture of innovation and knowledge sharing within the industry.

Conclusion: Lars Bärfacker's relentless pursuit of innovation and his commitment to pushing the boundaries of pharmaceutical research make him a trailblazer in the field. With his impressive patent portfolio and impactful collaborations, Lars Bärfacker continues to inspire future generations of inventors and researchers in the quest for groundbreaking discoveries.

I hope this article sheds light on the remarkable achievements of inventor Lars Bärfacker in the realm of innovations and patents. If you need further information or details, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…